Literature DB >> 28160734

Causes of death and expected years of life lost among treated opioid-dependent individuals in the United States and Taiwan.

Kun-Chia Chang1, Jung-Der Wang2, Andrew Saxon3, Abigail G Matthews4, George Woody5, Yih-Ing Hser6.   

Abstract

AIMS: This study compared the cause-specific standardized mortality ratios (SMRs) and expected years of life lost (EYLL) among opioid-dependent individuals in the United States and Taiwan.
METHODS: Survival data came from two cohorts followed until 2014: The U.S. data were based on a randomized trial of 1267 opioid-dependent participants enrolled between 2006 and 2009; the Taiwan data were from a study of 983 individuals that began in 2006, when opioid agonist treatment (OAT) was implemented in Taiwan. SMRs were calculated for each national cohort and compared. Kaplan-Meier estimation was performed on the survival data, then lifespans were extrapolated to 70 years (840 months) to estimate life expectancy using a semi-parametric method. EYLLs for both cohorts were estimated by subtracting their life expectancies from the age- and gender-matched referents within the general population of their respective country.
RESULTS: Compared with age- and gender-matched referents, the SMRs were 3.2 for the U.S. sample and 7.8 for the Taiwan sample; the EYLLs were 7.7 and 16.4 years, respectively. Half of decedents died of unnatural causes in both cohorts; overdose deaths predominated in the U.S. and suicide in Taiwan.
CONCLUSIONS: Our study identified differences by country in EYLL and causes of deaths. These findings suggest that intervention strategies to reduce mortality risk by overdose (particularly in the U.S.) and suicide (particularly in Taiwan) are urgently needed in these countries.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Life expectancy; Mortality; Opioid; Overdose; Suicide

Mesh:

Substances:

Year:  2017        PMID: 28160734      PMCID: PMC5420493          DOI: 10.1016/j.drugpo.2016.12.003

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  31 in total

1.  Years of potential life lost among heroin addicts 33 years after treatment.

Authors:  Breda Smyth; Valerie Hoffman; Jing Fan; Yih-Ing Hser
Journal:  Prev Med       Date:  2007-02-08       Impact factor: 4.018

2.  Estimation of life expectancy and the expected years of life lost among heroin users in the era of opioid substitution treatment (OST) in Taiwan.

Authors:  Kun-Chia Chang; Tsung-Hsueh Lu; Kuan-Ying Lee; Jing-Shiang Hwang; Ching-Ming Cheng; Jung-Der Wang
Journal:  Drug Alcohol Depend       Date:  2015-05-28       Impact factor: 4.492

3.  President Obama Proposes $1.1 Billion in New Funding to Address the Prescription Opioid Abuse and Heroin Use Epidemic.

Authors: 
Journal:  J Pain Palliat Care Pharmacother       Date:  2016-06

4.  Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.

Authors:  Phillip O Coffin; Sean D Sullivan
Journal:  Ann Intern Med       Date:  2013-01-01       Impact factor: 25.391

5.  Suicide and other-cause mortality among heroin users in Taiwan: a prospective study.

Authors:  Charles T C Lee; Vincent C H Chen; Happy K L Tan; Sun-Yuan Chou; Kuen-Hong Wu; Chia-Hsiang Chan; Michael Gossop
Journal:  Addict Behav       Date:  2013-03-21       Impact factor: 3.913

6.  Mental illness and suicide. A case-control study in east Taiwan.

Authors:  A T Cheng
Journal:  Arch Gen Psychiatry       Date:  1995-07

7.  Gender differences in mortality among treated opioid dependent patients.

Authors:  E Evans; A Kelleghan; L Li; J Min; D Huang; D Urada; Y I Hser; B Nosyk
Journal:  Drug Alcohol Depend       Date:  2015-07-17       Impact factor: 4.492

8.  Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment.

Authors:  Jo Kimber; Lorraine Copeland; Matthew Hickman; John Macleod; James McKenzie; Daniela De Angelis; James Roy Robertson
Journal:  BMJ       Date:  2010-07-01

9.  Causes of death in a cohort treated for opioid dependence between 1985 and 2005.

Authors:  Louisa Degenhardt; Sarah Larney; Deborah Randall; Lucy Burns; Wayne Hall
Journal:  Addiction       Date:  2013-10-09       Impact factor: 6.526

10.  Years of potential life lost amongst heroin users in the Australian Treatment Outcome Study cohort, 2001-2015.

Authors:  Shane Darke; Christina Marel; Katherine L Mills; Joanne Ross; Tim Slade; Maree Tessson
Journal:  Drug Alcohol Depend       Date:  2016-03-18       Impact factor: 4.492

View more
  10 in total

1.  Trends In Substance Use And Related Disorders: Analysis of the Epidemiological Survey of Substance Abuse 1995 to 2018.

Authors:  Nicki-Nils Seitz; Kirsten Lochbühler; Josefine Atzendorf; Christian Rauschert; Tim Pfeiffer-Gerschel; Ludwig Kraus
Journal:  Dtsch Arztebl Int       Date:  2019-09-02       Impact factor: 5.594

2.  Primary care and medication management characteristics among patients receiving office-based opioid treatment with buprenorphine.

Authors:  Cindy Xinxin Du; Julia Shi; Jeanette M Tetrault; Lynn M Madden; Declan T Barry
Journal:  Fam Pract       Date:  2022-03-24       Impact factor: 2.267

3.  Long-term Infective Endocarditis Mortality Associated With Injection Opioid Use in the United States: A Modeling Study.

Authors:  Joshua A Barocas; Golnaz Eftekhari Yazdi; Alexandra Savinkina; Shayla Nolen; Caroline Savitzky; Jeffrey H Samet; Honora Englander; Benjamin P Linas
Journal:  Clin Infect Dis       Date:  2021-12-06       Impact factor: 9.079

Review 4.  A Review of the Opioid Epidemic: What Do We Do About It?

Authors:  Edward A Shipton; Elspeth E Shipton; Ashleigh J Shipton
Journal:  Pain Ther       Date:  2018-04-06

5.  Psychological distress mediated the effects of self-stigma on quality of life in opioid-dependent individuals: A cross-sectional study.

Authors:  Kun-Chia Chang; Chung-Ying Lin; Chih-Cheng Chang; Shuo-Yen Ting; Ching-Ming Cheng; Jung-Der Wang
Journal:  PLoS One       Date:  2019-02-06       Impact factor: 3.240

6.  Analgesic Opioid Misuse and Opioid Use Disorder among Patients with Chronic Non-Cancer Pain and Prescribed Opioids in a Pain Centre in France.

Authors:  Morgane Guillou-Landreat; Bertrand Quinio; Jean Yves Le Reste; Delphine Le Goff; Jérôme Fonsecca; Marie Grall-Bronnec; Antoine Dany
Journal:  Int J Environ Res Public Health       Date:  2021-02-21       Impact factor: 3.390

7.  Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study.

Authors:  Joshua A Barocas; Alexandra Savinkina; Joella Adams; Raagini Jawa; Zoe M Weinstein; Jeffrey H Samet; Benjamin P Linas
Journal:  Lancet Public Health       Date:  2021-11-30

8.  Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis.

Authors:  Joëlla W Adams; Alexandra Savinkina; James C Hudspeth; Mam Jarra Gai; Raagini Jawa; Laura R Marks; Benjamin P Linas; Alison Hill; Jason Flood; Simeon Kimmel; Joshua A Barocas
Journal:  JAMA Netw Open       Date:  2022-02-01

9.  A Retrospective Administrative Database Analysis of Suicide Attempts and Completed Suicide in Patients With Chronic Pancreatitis.

Authors:  Chien-Hua Chen; Cheng-Li Lin; Chung-Y Hsu; Chia-Hung Kao
Journal:  Front Psychiatry       Date:  2018-04-18       Impact factor: 4.157

10.  Unnatural Death among Treatment Seeking Substance Users in Singapore: A Retrospective Study.

Authors:  Asharani Pv; Tan Jun Wen; Mohamed Zakir Karuvetil; Alvin Cheong; Christopher Cheok; Gomathinayagam Kandasami
Journal:  Int J Environ Res Public Health       Date:  2019-07-31       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.